- Home
- MTCH vs HALO Comparison
MTCH vs HALO Comparison
Compare MTCH & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTCH
- HALO
- Stock Information
- Founded
- MTCH 1986
- HALO 1998
- Country
- MTCH United States
- HALO United States
- Employees
- MTCH N/A
- HALO N/A
- Industry
- MTCH Computer Software: Programming Data Processing
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MTCH Technology
- HALO Health Care
- Exchange
- MTCH Nasdaq
- HALO Nasdaq
- Market Cap
- MTCH 7.2B
- HALO 7.4B
- IPO Year
- MTCH 2015
- HALO N/A
- Fundamental
- Price
- MTCH $29.21
- HALO $54.54
- Analyst Decision
- MTCH Buy
- HALO Buy
- Analyst Count
- MTCH 19
- HALO 9
- Target Price
- MTCH $35.89
- HALO $63.56
- AVG Volume (30 Days)
- MTCH 5.5M
- HALO 3.3M
- Earning Date
- MTCH 05-08-2025
- HALO 05-06-2025
- Dividend Yield
- MTCH 1.30%
- HALO N/A
- EPS Growth
- MTCH N/A
- HALO 55.40
- EPS
- MTCH 2.03
- HALO 3.76
- Revenue
- MTCH $3,450,904,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- MTCH $1.20
- HALO $25.77
- Revenue Next Year
- MTCH $4.15
- HALO $18.01
- P/E Ratio
- MTCH $14.41
- HALO $14.51
- Revenue Growth
- MTCH 0.40
- HALO 25.64
- 52 Week Low
- MTCH $26.39
- HALO $42.01
- 52 Week High
- MTCH $38.84
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- MTCH 48.16
- HALO 44.48
- Support Level
- MTCH $28.80
- HALO $52.43
- Resistance Level
- MTCH $30.45
- HALO $54.26
- Average True Range (ATR)
- MTCH 1.00
- HALO 3.42
- MACD
- MTCH 0.07
- HALO -0.49
- Stochastic Oscillator
- MTCH 60.86
- HALO 30.60
About MTCH Match Group Inc.
Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. The company generates the majority of its revenue from the Tinder segment.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.